Myasthenia gravis as a complication of D-penicillamine treatment in rheumatoid arthritis
Ongerboer de Visser, B.W.; van Soesbergen, R.M.
Nederlands Tijdschrift Voor Geneeskunde 122(52): 2055-2058
1978
ISSN/ISBN: 0028-2162 PMID: 732905 Document Number: 132277
Document emailed within 1 workday
Related Documents
Gordon, R.A.; Burnside, J.W. 1977: D-Penicillamine-induced myasthenia gravis in rheumatoid arthritis Annals of Internal Medicine 87(5): 578-579Vincent, A.; Newsom-Davis, J. 1982: Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset Clinical and Experimental Immunology 49(2): 266-272
Murakami, S. 1976: 2 cases of myasthenia gravis associated with rheumatoid arthritis - a study of autoimmune diseases Rinsho Shinkeigaku 16(2): 110-116
Mizuno, T.; Hashimoto, T.; Hibino, N.; Nakamae, K.; Masaoka, A. 1988: A case of myasthenia gravis associated with rheumatoid arthritis, Sjögren's syndrome, hypergammaglobulinemia and hyperthyroidism Nihon Kyobu Geka Gakkai 36(7): 1191-1193
Egashira, K.; Yamamoto, T.; Tsuji, S.; Ohnishi, A.; Murai, Y. 1987: A case of myasthenia gravis complicated with chronic rheumatoid arthritis and Vogt-Koyanagi-Harada disease Rinsho Shinkeigaku 27(7): 859-861
Rousseau, J.J.; Dieudonne, L.G. 1980: Myasthenia gravis syndrome following administration of d-penicillamine Acta Neurologica Belgica 80(3): 165-173
Kutsuna, T.; Maeda, K.; Okamoto, T. 1986: Long-term results of D-penicillamine treatment in rheumatoid arthritis Ryumachi 26(4): 270-277
Shiokawa, Y.; Horiuchi, T.; Honma, M.; Kageyama, T.; Okada, T. 1977: Clinical evaluation of D-penicillamine for the treatment of rheumatoid arthritis by a double blind test Ryumachi 17(2): 205-210
Azuma, T.; Sugawara, S.; Maeda, A.; Miyauchi, T.; Aritomi, H. 1986: Long-term comparative studies on gold, D-penicillamine, and NSAIDs for the treatment of early rheumatoid arthritis. 1. Evaluation of one year's treatment Ryumachi 26(3): 200-209
Moens, H.J.; Ament, B.J.; Feltkamp, B.W.; van der Korst, J.K. 1987: Longterm followup of treatment with D-penicillamine for rheumatoid arthritis: effectivity and toxicity in relation to HLA antigens Journal of Rheumatology 14(6): 1115-1119
Bonnet, M.; Angibaud, G.; Cantagrel, A.; Montastruc, J.L.; Clanet, M. 1995: Myasthenia induced by tiopronin in the treatment of rheumatoid arthritis Revue Neurologique (Paris) 151(1): 67-68
Ng, C.V.T. 2006: Myasthenia gravis and a rare complication of chemotherapy - clarification and acknowledgement Medical Journal of Australia 184(6): 312
Szobor, A. 1989: Myasthenia gravis: familial occurrence. A study of 1100 myasthenia gravis patients Acta Medica Hungarica 46(1): 13-21
Krel', A.A.; Kanevskaia, M.Z.; Rashchupkina, Z.P.; Bolotin, E.V.; Chichasova, N.V. 1981: Chlorbutin, azathioprine, D-penicillamine, and levamisole (Decaris) in the treatment of rheumatoid arthritis patients. I. Comparative analysis of side effects Terapevticheskii Arkhiv 53(7): 86-96
Nau, R.; Behrends, T.; Henze, T.; Prange, H.W. 1989: Central nervous system infection caused by Aspergillus fumigatus. A complication of immunosuppressive therapy in myasthenia gravis Der Nervenarzt 60(3): 178-180
Seideman, P.; Lindström, B. 1989: Pharmacokinetic interactions of penicillamine in rheumatoid arthritis Journal of Rheumatology 16(4): 473-474
Brenner, S.; Caspi, D.; Tchetchik, R.; Krakowski, A.; Yaron, M. 1983: Pemphigus folliaceous following D-penicillamine in rheumatoid arthritis Harefuah 104(3): 94-96
Waskönig, F.W.; Meyer, W. 1973: The basal therapy of rheumatoid arthritis with d-penicillamine Münchener Medizinische Wochenschrift 115(45): 2047-2050
Huskisson, E.C. 1981: The side effects of penicillamine therapy in rheumatoid arthritis Journal of Rheumatology. Suppl 7: 146-148
Matthey, F.; Perrett, D.; Greenwood, R.N.; Baker, L.R. 1986: The use of D-penicillamine in patients with rheumatoid arthritis undergoing hemodialysis Clinical Nephrology 25(5): 268-271